NATURES SUNSHINE PRODUCTS INC - Common Stock, no par value per share (NATR)

CUSIP: 639027101

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+790
SEC-reported price per share
$12.69
Number of holders
2
Value change
+$9,961
Number of buys
1
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
17,655,835

Security key

639027101

Report period

Q3 2026

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of NATR - NATURES SUNSHINE PRODUCTS INC - Common Stock, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRESCOTT GROUP CAPITAL MA...
Disclosed value leader
PRESCOTT GROUP CAPITAL MA...
Comparable rows
15/15
Latest evidence
02 Sep 2026
13D/G 3/4/5 13F Lead comparable stake: 11% 13D/G row: PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. Showing 1-6 of 15 holder rows.

Quick read

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.'s linked filing trail.
Comparable ownership Top 5
PRESCOTT GROUP CAPITAL MANAGEMENT... 11%
DIMENSIONAL FUND ADVISORS LP 5.2%
BlackRock, Inc. 5%
Shanghai Fosun Pharmaceutical (Gr... 0.35%
Fosun Pharma USA Inc. 16%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
13D/G 3/4/5 13F
10%+ Owner · Company
11%
$42,242,468
1,924,486 shares
$0 06 Aug 2026
DIMENSIONAL FUND ADVISORS LP
13F 13D/G
Company
5.2%
from 13D/G
$20,134,573
923,626 shares
— 30 Jun 2026
BlackRock, Inc.
13F 13D/G
Company
5%
from 13D/G
$21,560,637
989,020 shares
— 30 Jun 2026
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
13D/G 3/4/5
10%+ Owner
0.35%
$735,354
64,167 shares
-$32,713,796 25 Jun 2025
Fosun Pharma USA Inc.
3/4/5
10%+ Owner
16%
$32,713,796
2,854,607 shares
— 05 Jun 2025
Phil Frohlich
3/4/5
10%+ Owner
11%
$28,564,499
1,944,486 shares
+$2,612,712 17 Aug 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
1,922
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
151
Q3 2026 holders
2
Holder diff
-149
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .